The β-lactamase of Pseudomonas aeruginosa is known to degrade β-lactam antibiotics
such as penicillins, cephalosporins, monobactams, and carbapenems. With the discovery of …

Drug resistance is an unsolved and major concern in the bacterial infection. Continuous
development of drug-resistance to the antibiotics exponentially rises the danger of bacterial …

Abstract β-lactam resistance in bacteria is primarily mediated through the production of β-
lactamases. Among the several strategies explored to mitigate the issue of β-lactam …

Antibiotic-resistant microbes have emerged around the world, presenting a risk to health.
Plant-derived drugs have become a potential source for the production of antibiotic-resistant …

Introduction Antibacterial drugs have been widely used for the past century to treat diseases,
but their efficacy has been limited by multi-resistant pathogens, particularly those that utilize …

Antibiotic resistance remains one of the global challenges that needs urgent attention,
including finding alternative treatment options to conventional antibiotics and reversing …

Methicillin-resistant Staphylococcus aureus (MRSA) is a critical pathogen responsible for a
wide variety of serious infectious diseases in humans. The accelerated phenomena of drug …

Background: Klebsiella pneumoniae is known as an extended spectrum beta (β)-lactamases
(ESBLs)-producing bacteria, which produces enzymes that cause resistance to β-lactam …

Antibiotic resistance is threatening the medical industry in treating microbial infections. Many
organisms are acquiring antibiotic resistance because of the continuous use of the same …

Abstract β-Lactamases are enzymes that catalyze the hydrolysis of the β-lactam ring,
resulting in loss of function in β-lactam antibiotics. In this report, the inhibition of β-lactamase …